Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
about
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundRelationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Nonalcoholic fatty liver disease - A multisystem disease?Psoriasis and comorbid diseases: Epidemiology.Co-morbidity in psoriasis: mechanisms and implications for treatment.Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.Nonalcoholic fatty liver disease: Evolving paradigms.Increased risk of psoriasis in individuals with childhood asthma: therapeutic implications?Comparison of enhanced liver fibrosis test with procollagen-3 N-terminal peptide (P3NP) as a marker for liver fibrosis.A Case-control Study to Evaluate the Prevalence of Nonalcoholic Fatty Liver Disease Among Patients with Moderate-to-severe Psoriasis.
P2860
Q26765175-9B3388A9-BADE-42D5-9F27-FC994334C174Q26767276-A9C1C0D6-3F0F-4A09-96E1-01AE30F9A909Q28079077-BEE5ED0F-C921-47DD-A09B-E187EF6EF279Q30235889-7594E414-2A14-41C2-9FE0-1FD67FD4E408Q30248952-F34EECFB-412A-4256-8890-33EB2DA1F2DBQ35860158-670A3684-22F8-4BA5-BDAC-5A77050C563AQ36252677-09C55201-1D20-49FC-907D-B718CCC194A5Q38893359-41389BBB-4930-4EB7-A2C7-1CCC3912A22BQ39124718-D8F25EC7-C595-4895-AA7E-19F00E35EBF9Q40311189-F54C513E-EE17-4BF8-99D1-5E7F643B779AQ41133262-A2034BB7-98FB-46E2-A488-0F721D65069CQ42695154-2988DA1C-83C2-4499-B3F1-26273326A534Q48158799-C36069F0-B76C-4476-BDA6-2707ECC5AE21Q50959375-E7139BA1-567A-403C-97FB-A4C8BEA3A781Q55255755-2C851AB1-07D2-48FB-AB71-EB85B95AB817
P2860
Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Risk of non-alcoholic fatty li ...... atic review and meta-analysis.
@ast
Risk of non-alcoholic fatty li ...... atic review and meta-analysis.
@en
type
label
Risk of non-alcoholic fatty li ...... atic review and meta-analysis.
@ast
Risk of non-alcoholic fatty li ...... atic review and meta-analysis.
@en
prefLabel
Risk of non-alcoholic fatty li ...... atic review and meta-analysis.
@ast
Risk of non-alcoholic fatty li ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
Risk of non-alcoholic fatty li ...... atic review and meta-analysis.
@en
P2093
N Chávez-Tapia
N Méndez-Sánchez
R Torres-Robles
P2860
P304
P356
10.1111/JDV.12847
P577
2014-11-21T00:00:00Z